These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 28438108

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. The effect of 17-allylamino-17-demethoxygeldanamycin alone or in combination with paclitaxel on anaplastic thyroid carcinoma cells.
    Kim SH, Kang JG, Kim CS, Ihm SH, Choi MG, Yoo HJ, Lee SJ.
    Endocrine; 2015 Apr; 48(3):886-93. PubMed ID: 25096912
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The Hsp90 inhibitor 17-allylamide-17-demethoxygeldanamycin induces apoptosis and differentiation of Kasumi-1 harboring the Asn822Lys KIT mutation and down-regulates KIT protein level.
    Yu W, Rao Q, Wang M, Tian Z, Lin D, Liu X, Wang J.
    Leuk Res; 2006 May; 30(5):575-82. PubMed ID: 16213582
    [Abstract] [Full Text] [Related]

  • 34. YM155 enhances the cytotoxic activity of etoposide against canine osteosarcoma cells.
    Ong SM, Saeki K, Kok MK, Nakagawa T, Nishimura R.
    J Vet Med Sci; 2019 Aug 24; 81(8):1182-1190. PubMed ID: 31308291
    [Abstract] [Full Text] [Related]

  • 35. In vitro retinoid-induced growth inhibition and morphologic differentiation of canine osteosarcoma cells.
    Hong SH, Kadosawa T, Nozaki K, Mochizuki M, Matsunaga S, Nishimura R, Sasaki N.
    Am J Vet Res; 2000 Jan 24; 61(1):69-73. PubMed ID: 10630782
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Acquired resistance to HSP90 inhibitor 17-AAG and increased metastatic potential are associated with MUC1 expression in colon carcinoma cells.
    Liu X, Ban LL, Luo G, Li ZY, Li YF, Zhou YC, Wang XC, Jin CG, Ye JG, Ma DD, Xie Q, Huang YG.
    Anticancer Drugs; 2016 Jun 24; 27(5):417-26. PubMed ID: 26872308
    [Abstract] [Full Text] [Related]

  • 38. Multiple kinase pathways involved in the different de novo sensitivity of pancreatic cancer cell lines to 17-AAG.
    Liu H, Zhang T, Chen R, McConkey DJ, Ward JF, Curley SA.
    J Surg Res; 2012 Jul 24; 176(1):147-53. PubMed ID: 22099584
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Biological activity of gemcitabine against canine osteosarcoma cell lines in vitro.
    McMahon MB, Bear MD, Kulp SK, Pennell ML, London CA.
    Am J Vet Res; 2010 Jul 24; 71(7):799-808. PubMed ID: 20594083
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.